Literature DB >> 23935124

Associations of age and sex with the clinical outcome and incubation period of Shiga toxin-producing Escherichia coli O104:H4 infections, 2011.

Dirk Werber, Lisa A King, Luise Müller, Per Follin, Udo Buchholz, Helen Bernard, Bettina Rosner, Steen Ethelberg, Henriette de Valk, Michael Höhle.   

Abstract

We pooled data on adults who reported diarrhea or developed life-threatening hemolytic uremic syndrome (HUS) in any of 6 closed cohorts from 4 countries (1 cohort each in Denmark, France, and Sweden and 3 in Germany) that were investigated during a large outbreak of Shiga toxin-producing Escherichia coli (STEC) O104:H4 infection in 2011. Logistic regression and Weibull regression for interval censored data were used to assess the relation of age and sex with clinical outcome and with incubation period. Information on the latter was used in a nonparametric back-projection context to estimate when adult cases reported in Germany were exposed to STEC O104:H4. Overall, data from 119 persons (median age, 49 years; 80 women) were analyzed. Bloody diarrhea and HUS were recorded as the most severe outcome for 44 and 26 individuals, respectively. Older age was significantly associated with bloody diarrhea but not with HUS. Woman had nonsignificantly higher odds for bloody diarrhea (odds ratio = 1.81) and developing HUS (odds ratio = 1.83) than did men. Older participants had a statistically significantly reduced incubation period. The shortest interval that included 75% of exposures in adults spanned only 12 days and preceded outbreak detection. In conclusion, the frequency of bloody diarrhea but not of HUS and the length of the incubation period depended on the age of individuals infected with STEC O104:H4. A large number of people were exposed to STEC O104:H4 for a short period of time.

Entities:  

Keywords:  Escherichia coli; Shiga toxin 2; Shiga-toxigenic Escherichia coli; disease outbreaks; hemolytic uremic syndrome; public health

Mesh:

Year:  2013        PMID: 23935124     DOI: 10.1093/aje/kwt069

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  10 in total

Review 1.  A review of back-calculation techniques and their potential to inform mitigation strategies with application to non-transmissible acute infectious diseases.

Authors:  Joseph R Egan; Ian M Hall
Journal:  J R Soc Interface       Date:  2015-05-06       Impact factor: 4.118

Review 2.  Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care Management.

Authors:  Benoit Travert; Cédric Rafat; Patricia Mariani; Aurélie Cointe; Antoine Dossier; Paul Coppo; Adrien Joseph
Journal:  Toxins (Basel)       Date:  2021-04-26       Impact factor: 4.546

3.  Investigation of travel-related cases in a multinational outbreak: example of the Shiga-toxin producing E. coli outbreak in Germany, May-June 2011.

Authors:  I Devaux; C Varela-Santos; L Payne-Hallström; J Takkinen; C Bogaardt; D Coulombier
Journal:  Epidemiol Infect       Date:  2015-04-24       Impact factor: 4.434

Review 4.  Public Health Research Resulting from One of the World's Largest Outbreaks Caused by Entero-Hemorrhagic Escherichia coli in Germany 2011: A Review.

Authors:  Elena Köckerling; Laura Karrasch; Aparna Schweitzer; Oliver Razum; Gérard Krause
Journal:  Front Public Health       Date:  2017-12-11

5.  Assessment of recall error in self-reported food consumption histories among adults-Particularly delay of interviews decrease completeness of food histories-Germany, 2013.

Authors:  Maximilian Gertler; Irina Czogiel; Klaus Stark; Hendrik Wilking
Journal:  PLoS One       Date:  2017-06-22       Impact factor: 3.240

6.  Incubation Period of Shiga Toxin-Producing Escherichia coli.

Authors:  Adedoyin Awofisayo-Okuyelu; Julii Brainard; Ian Hall; Noel McCarthy
Journal:  Epidemiol Rev       Date:  2019-01-31       Impact factor: 6.222

7.  Shiga toxin type-2 (Stx2) induces glutamate release via phosphoinositide 3-kinase (PI3K) pathway in murine neurons.

Authors:  Fumiko Obata; Lauren M Hippler; Progyaparamita Saha; Dakshina M Jandhyala; Olga S Latinovic
Journal:  Front Mol Neurosci       Date:  2015-07-14       Impact factor: 5.639

8.  Shiga toxin-producing escherichia coli infections in Norway, 1992-2012: characterization of isolates and identification of risk factors for haemolytic uremic syndrome.

Authors:  Lin T Brandal; Astrid L Wester; Heidi Lange; Inger Løbersli; Bjørn-Arne Lindstedt; Line Vold; Georg Kapperud
Journal:  BMC Infect Dis       Date:  2015-08-11       Impact factor: 3.090

9.  Shiga toxin-producing Escherichia coli O157 is more likely to lead to hospitalization and death than non-O157 serogroups--except O104.

Authors:  Karina Preußel; Michael Höhle; Klaus Stark; Dirk Werber
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

10.  Therapeutic use of a receptor mimic probiotic reduces intestinal Shiga toxin levels in a piglet model of hemolytic uremic syndrome.

Authors:  Shannon J Hostetter; Amy F Helgerson; James C Paton; Adrienne W Paton; Nancy A Cornick
Journal:  BMC Res Notes       Date:  2014-06-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.